54.174.225.82
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

FDA Alerts

FDA approves first treatment for adult patients with active lupus nephritis

The US Food and Drug Administration approved the intravenous and subcutaneous formulations of belimumab (Benlysta; GSK) for the treatment of adult patients with active lupus nephritis (LN) who are receiving standard therapy, according to a press release. Belimumab was previously approved for the treatment of patients ≥5 years old with...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-